Position in BMRN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$986,816
-$582,419 QoQ
Shares Held
17,246
-37.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#271
of 555 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRIGHTON JONES LLC holds $23,861,614 across 48 Biotechnology names. BMRN ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
36,050 | $4,086,628 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,048 | $3,997,683 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,325 | $2,696,810 | |
| 4 | EXEL |
Exelixis, Inc.
|
40,712 | $2,215,139 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,898 | $1,474,444 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
17,246 | $986,816 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,466 | $649,112 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
7,463 | $648,907 |
All Filings in BMRN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $986,816 | 17,246 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,569,235 | 27,779 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $1,408,160 | 26,000 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,125,785 | 20,480 | Shares | Sole | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||